Human cytomegalovirus UL141 protein interacts with CELF5 and affects viral DNA replication

Zou,Fei; Lu,Zhi‑Tao; Wang,Shuang; Wu,Si; Wu,Ying‑Ying; Sun,Zheng‑Rong

doi:10.3892/mmr.2018.8419

Human cytomegalovirus UL141 protein interacts with CELF5 and affects viral DNA replication

Authors:
- Fei Zou
- Zhi‑Tao Lu
- Shuang Wang
- Si Wu
- Ying‑Ying Wu
- Zheng‑Rong Sun
View Affiliations

Affiliations: Department of BioBank, Affiliated Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, P.R. China, Department of Pediatrics, Zhangjiagang First People's Hospital, Zhangjiagang, Jiangsu 215600, P.R. China
Published online on: January 10, 2018 https://doi.org/10.3892/mmr.2018.8419
Pages: 4657-4664

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Human cytomegalovirus (HCMV) infection is the primary viral cause of congenital abnormalities and mental retardation in newborns. The HCMV UL141‑encoded glycoprotein has been previously revealed to inhibit the cell‑surface expression of cluster of differentiation (CD)155, CD122, tumor necrosis factor‑related apoptosis‑inducing ligand death (TRAIL)‑receptor 1 (R1) and TRAIL‑receptor 2 (R2), thus protecting virally‑infected cells by allowing them to escape natural killer cell‑mediated cytotoxicity. The present study investigated the interaction between HCMV UL141 and human fetal brain cDNA to elucidate the possible effects of UL141 on the nervous system. The findings of the current study demonstrate that the HCMV UL141 protein directly interacts with the human protein CUGBP Elav‑like family member 5 (CELF5) via yeast two‑hybrid screening, this interaction was confirmed by glutathione S‑transferase pull‑down and co‑immunoprecipitation assays. Additionally, the present study demonstrated that the UL141 protein co‑localizes with CELF5 in the cytoplasm of 293 cells using fluorescence confocal microscopy. CELF5 overexpression in a stably‑expressing cell line significantly increased viral DNA copy number and titer in HCMV‑infected U373MG cells. However, reducing CELF5 expression via specific small interfering RNAs did not affect viral DNA copy number or titer in HCMV‑infected cells. The current findings suggest that the interaction between UL141 and CELF5 may be involved in modulating viral DNA synthesis and progeny production. Therefore, CELF5 may represent a possible mechanism for regulation of HCMV genomic DNA synthesis, which is a key step during HCMV infection leading to neurological disease.

View Figures

View References

1	Manicklal S, Emery VC, Lazzarotto T, Boppana SB and Gupta RK: The ‘silent’ global burden of congenital cytomegalovirus. Clin Microbiol Rev. 26:86–102. 2013. View Article : Google Scholar : PubMed/NCBI
2	Huang ZR, Yu LP, Yang XC, Zhang F, Chen YR, Feng F, Qian XS and Cai J: Human cytomegalovirus linked to stroke in a Chinese population. CNS Neurosci Ther. 18:457–460. 2012. View Article : Google Scholar : PubMed/NCBI
3	Dziurzynski K, Chang SM, Heimberger AB, Kalejta RF, McGregor Dallas SR, Smit M, Soroceanu L and Cobbs CS: HCMV and Gliomas Symposium: Consensus on the role of human cytomegalovirus in glioblastoma. Neuro Oncol. 14:246–255. 2012. View Article : Google Scholar : PubMed/NCBI
4	Sinzger C, Digel M and Jahn G: Cytomegalovirus cell tropism. Curr Top Microbiol Immunol. 325:63–83. 2008.PubMed/NCBI
5	Gredmark-Russ S and Söderberg-Nauclér C: Dendritic cell biology in human cytomegalovirus infection and the clinical consequences for host immunity and pathology. Virulence. 3:621–634. 2012. View Article : Google Scholar : PubMed/NCBI
6	Dolan A, Cunningham C, Hector RD, Hassan-Walker AF, Lee L, Addison C, Dargan DJ, McGeoch DJ, Gatherer D, Emery VC, et al: Genetic content of wild-type human cytomegalovirus. J Gen Virol. 85:1301–1312. 2004. View Article : Google Scholar : PubMed/NCBI
7	Tomasec P, Wang EC, Davison AJ, Vojtesek B, Armstrong M, Griffin C, McSharry BP, Morris RJ, Llewellyn-Lacey S, Rickards C, et al: Downregulation of natural killer cell-activating ligand CD155 by human cytomegalovirus UL141. Nat Immunol. 6:181–188. 2005. View Article : Google Scholar : PubMed/NCBI
8	Prod'homme V, Sugrue DM, Stanton RJ, Nomoto A, Davies J, Rickards CR, Cochrane D, Moore M, Wilkinson GW and Tomasec P: Human cytomegalovirus UL141 promotes efficient downregulation of the natural killer cell activating ligand CD112. J Gen Virol. 91:2034–2039. 2010. View Article : Google Scholar : PubMed/NCBI
9	Nemčovičová I, Benedict CA and Zajonc DM: Structure of human cytomegalovirus UL141 binding to TRAIL-R2 reveals novel, non-canonical death receptor interactions. PLoS Pathog. 9:e10032242013. View Article : Google Scholar : PubMed/NCBI
10	Hsu JL, Van den Boomen DJ, Tomasec P, Weekes MP, Antrobus R, Stanton RJ, Ruckova E, Sugrue D, Wilkie GS, Davison AJ, et al: Plasma membrane profiling defines an expanded class of cell surface proteins selectively targeted for degradation by HCMV US2 in cooperation with UL141. PLoS Pathog. 11:e10048112015. View Article : Google Scholar : PubMed/NCBI
11	Murrell I, Wilkie GS, Davison AJ, Statkute E, Fielding CA, Tomasec P, Wilkinson GW and Stanton RJ: Genetic stability of bacterial artificial chromosome-derived human cytomegalovirus during culture in vitro. J Virol. 90:3929–3943. 2016. View Article : Google Scholar : PubMed/NCBI
12	Wang G, Ren G, Cui X, Lu Z, Ma Y, Qi Y, Huang Y, Liu Z, Sun Z and Ruan Q: Human cytomegalovirus RL13 protein interacts with host NUDT14 protein affecting viral DNA replication. Mol Med Rep. 13:2167–2174. 2016. View Article : Google Scholar : PubMed/NCBI
13	Ross SA and Boppana SB: Congenital cytomegalovirus infection: Outcome and diagnosis. Semin Pediatr Infect Dis. 16:44–49. 2005. View Article : Google Scholar : PubMed/NCBI
14	Wang G, Ren G, Cui X, Lu Z, Ma Y, Qi Y, Huang Y, Liu Z, Sun Z and Ruan Q: Host protein Snapin interacts with human cytomegalovirus pUL130 and affects viral DNA replication. J Biosci. 41:173–182. 2016. View Article : Google Scholar : PubMed/NCBI
15	McMahon TP and Anders DG: Interactions between human cytomegalovirus helicase-primase proteins. Virus Res. 86:39–52. 2002. View Article : Google Scholar : PubMed/NCBI
16	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
17	Zavattoni M, Rustico M, Tassis B, Lombardi G, Furione M, Piralla A and Baldanti F: Risk of congenital disease in 46 infected fetuses according to gestational age of primary human cytomegalovirus infection in the mother. J Med Virol. 88:120–126. 2016. View Article : Google Scholar : PubMed/NCBI
18	Xu LL, Mou WF, Yang L and Wang YC: Application of HCMV DNA detection in infants' blood, urine and mothers' breast milk in the diagnosis of HCMV infection among infants. Zhongguo Dang Dai Er Ke Za Zhi. 15:748–750. 2013.(In Chinese). PubMed/NCBI
19	Choudhary A, Pati SK, Patro RK, Deorari AK and Dar L: Comparison of conventional, immunological and molecular techniques for the diagnosis of symptomatic congenital human cytomegalovirus infection in neonates and infants. Indian J Med Microbiol. 33 Suppl:15–19. 2015. View Article : Google Scholar : PubMed/NCBI
20	Noriega V, Redmann V, Gardner T and Tortorella D: Diverse immune evasion strategies by human cytomegalovirus. Immunol Res. 54:140–151. 2012. View Article : Google Scholar : PubMed/NCBI
21	Wilkinson GW, Tomasec P, Stanton RJ, Armstrong M, Prod'homme V, Aicheler R, McSharry BP, Rickards CR, Cochrane D, Llewellyn-Lacey S, et al: Modulation of natural killer cells by human cytomegalovirus. J Clin Virol. 41:206–212. 2008. View Article : Google Scholar : PubMed/NCBI
22	Smith W, Tomasec P, Aicheler R, Loewendorf A, Nemčovičová I, Wang EC, Stanton RJ, Macauley M, Norris P, Willen L, et al: Human cytomegalovirus glycoprotein UL141 targets the TRAIL death receptors to thwart host innate antiviral defenses. Cell Host Microbe. 13:324–335. 2013. View Article : Google Scholar : PubMed/NCBI
23	David R: Immune evasion: UL141 keeps HCMV in charge. Nat Rev Microbiol. 11:2972013. View Article : Google Scholar : PubMed/NCBI
24	Loria PM, Duke A, Rand JB and Hobert O: Two neuronal, nuclear-localized RNA binding proteins involved in synaptic transmission. Curr Biol. 13:1317–1323. 2003. View Article : Google Scholar : PubMed/NCBI
25	Ladd AN, Charlet N and Cooper TA: The CELF family of RNA binding proteins is implicated in cell-specific and developmentally regulated alternative splicing. Mol Cell Biol. 21:1285–1296. 2001. View Article : Google Scholar : PubMed/NCBI
26	Dasgupta T and Ladd AN: The importance of CELF control: Molecular and biological roles of the CUG-BP, Elav-like family of RNA-binding proteins. Wiley Interdiscip Rev RNA. 3:104–121. 2012. View Article : Google Scholar : PubMed/NCBI
27	Gallo JM and Spickett C: The role of CELF proteins in neurological disorders. RNA Biol. 7:474–479. 2010. View Article : Google Scholar : PubMed/NCBI
28	Barron VA, Zhu H, Hinman MN, Ladd AN and Lou H: The neurofibromatosis type I pre-mRNA is a novel target of CELF protein-mediated splicing regulation. Nucleic Acids Res. 38:253–264. 2010. View Article : Google Scholar : PubMed/NCBI
29	Kalsotra A, Xiao X, Ward AJ, Castle JC, Johnson JM, Burge CB and Cooper TA: A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart. Proc Natl Acad Sci USA. 105:pp. 20333–20338. 2008; View Article : Google Scholar : PubMed/NCBI
30	Vlasova-St Louis I, Dickson AM, Bohjanen PR and Wilusz CJ: CELFish ways to modulate mRNA decay. Biochim Biophys Acta. 1829:695–707. 2013. View Article : Google Scholar : PubMed/NCBI
31	Kline RA, Kaifer KA, Osman EY, Carella F, Tiberi A, Ross J, Pennetta G, Lorson CL and Murray LM: Comparison of independent screens on differentially vulnerable motor neurons reveals alpha-synuclein as a common modifier in motor neuron diseases. PLoS Genet. 13:e10066802017. View Article : Google Scholar : PubMed/NCBI
32	Anderson KN, Baban D, Oliver PL, Potter A and Davies KE: Expression profiling in spinal muscular atrophy reveals an RNA binding protein deficit. Neuromuscul Disord. 14:711–722. 2004. View Article : Google Scholar : PubMed/NCBI
33	Wu J, Li C, Zhao S and Mao B: Differential expression of the Brunol/CELF family genes during Xenopus laevis early development. Int J Dev Biol. 54:209–214. 2010. View Article : Google Scholar : PubMed/NCBI